Copy Link Print Information

Tauroursodeoxycholate sodium

(Synonyms: Tauroursodeoxycholic acid sodium; TUDCA sodium; UR 906 sodium)
111 Cited Publications
Avis client

Based on 111 publication(s) in Google Scholar

Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 98.40%
  • CAS No.: 35807-85-3
  • Formule: C26H44NNaO6S
  • Masse moléculaire:521.69
  • Stockage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Tauroursodeoxycholate sodium Chemical Structure
    Tauroursodeoxycholate sodium Chemical Structure
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
  • Experimental Validation Results for Tauroursodeoxycholate sodium
CAS No.: 35807-85-3
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Tauroursodeoxycholate sodium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Tauroursodeoxycholate sodium

More
Customer Validation & Images
Histological Imaging/StainingIn Vivo Efficacy StudyWBRT-PCR
  • In Vivo Efficacy Study
  • Histological Imaging/Staining
  • RT-PCR
  • RT-PCR
  • WB
  • WB
  • WB
  • WB
  • WB
  • WB

Voir tous les produits spécifiques à Isoform ERK

More

Voir tous les produits spécifiques à Isoform Caspase

More

Voir tous les produits spécifiques à Isoform Endogenous Metabolite

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Tauroursodeoxycholate sodium Chemical Structure
    Tauroursodeoxycholate sodium Chemical Structure
    1/16
  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2026 Feb 9. [Abstract]

    Customer Validation
     RT-qPCR analysis of sXbp1, Cxcl10, and Ptprc (CD45) in cortices of mice with Tauroursodeoxycholate sodium (TUDCA, intraperitoneally at a dose of 50 mg/kg once daily) or saline administration at day 1 post-TBI.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Aug 16;16(1):7638. [Abstract]

    Customer Validation
     Representative images of mouse colon and H&E staining. Mice were treated with GUDCA or TUDCA (400 mg/kg, twice a week) after the AOM/DSS model was established (n = 8/group). H&E staining showed normal, dysplastic mucosae and carcinoma in the colon tissues.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Mar;12(12):e2411719. [Abstract]

    Customer Validation
     The mRNA levels of ALDOB in Huh7 or HCCLM3 cells treated with various bile acids (100 μM, 24 h). All data are presented as mean ± SD. Data were analyzed by one-way ANOVA with Bonferroni multiple-comparison correction. CA, cholic acid; TCA, taurocholic acid; GCA, glycocholic acid; TCDCA, taurochenodeoxycholic acid; GCDCA, glycochenodeoxycholic acid; LCA, lithocholic acid; TLCA, taurolithocholic acid; GLCA, glycolithocholic acid; DCA, deoxycholic acid; TDCA, taurodeoxycholic acid; GDCA, glycodeoxycholic acid; UDCA, ursodeoxycholic acid; TUDCA, tauroursodeoxycholic acid; GUDCA, glycoursodeoxycholic acid.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Nat Cell Biol. 2023 May;25(5):726-739. [Abstract]

    Customer Validation
     q-PCR analysis of ER stress markers in macrophages treated with vehicle or Tauroursodeoxycholate sodium (TUDCA) for 24 hr. n = 8 mice each, combined from 3 independent repeats.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Nat Cell Biol. 2023 May;25(5):726-739. [Abstract]

    Customer Validation
     Immunoblot of the STING pathway in macrophages pretreated with Tauroursodeoxycholate sodium (TUDCA) for 24 hr followed by DMXAA for another 1 hr. The numbers below the blot indicate relative band intensity of STING, p-STING (normalized to β-tubulin), or ratio of phosphorylated to total protein (p/t), representative of 2 independent repeats.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Mol Ther. 2023 Mar 1;31(3):890-908. [Abstract]

    Customer Validation
     Inhibition of ER stress by treatment with Tauroursodeoxycholate sodium (TUDCA, 100-500 nM, 24 h) prominently suppressed NLRP3 expression and the levels of active caspase-1 and IL-1β in MSC2D.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Mol Ther. 2023 Mar 1;31(3):890-908. [Abstract]

    Customer Validation
     MSC2D was treated with Tauroursodeoxycholate sodium (TUDCA, 100-500 nM) for 24 h.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: BMC Mol Cell Biol. 2023 Mar 3;24(1):7. [Abstract]

    Customer Validation
     Tauroursodeoxycholate (TUDCA; 2 mM) not only suppresses the expression of RPL11-induced ERS-related proteins but also markedly mitigates the expression of LC3-II and BECN1 and increases the expression of p62 in RPL11-overexpressing NSCLC cells.

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Biochem Pharmacol. 2018 Aug:154:278-292. [Abstract]

    Customer Validation
     TUDCA treatment inhibits the secretion of active IL-1β into cell culture media by Acetaminophen (APAP).

  • 1/16

    Tauroursodeoxycholate sodium purchased from MedChemExpress. Usage Cited in: Fundam Clin Pharmacol. 2018 Aug;32(4):363-377. [Abstract]

    Customer Validation
     Effect of TUDCA and Fluoxetine on chronic unpredictable stress (CUS)-induced increase in Iba-1 protein expression in mice hippocampus and prefrontal cortex.

  • Tauroursodeoxycholate sodium